← All industries · Healthcare
Industry

Industrial Instruments For Measurement

Every analyzed stock in Industrial Instruments For Measurement — 17 companies. Each card shows price, our model's intrinsic value (IV), and how far price sits above or below it. Click any card for the full analysis. This is a research-triage view, not a buy/sell signal.

Educational use only — not investment advice. "Undervalued / fairly valued / overvalued" and every risk score reflect our models vs. price, which can be wrong or based on stale or incomplete data. Always review the company's own financials and SEC filings, and consult a licensed advisor, before acting.
Sort by: A–Z Riskiest Most overvalued Most shorted Buyers' strike Largest
AME
AMETEK INC/
Deeply overvalued
Healthcare Risk 49 · Elevated
Price$256.22
Model IV$155.98
P/IV1.45
Premium +64% Return to IV: -39.1%
Market implies +13.5%/yr vs model +8.2% · above model
CGNX
COGNEX CORP
Deeply overvalued
Healthcare Risk 51 · Elevated
Price$61.59
Model IV$14.01
P/IV4.70
Premium +340% Return to IV: -77.3%
Market implies +24.9%/yr vs model +4.5% · above model
CLIR
ClearSign Technologies Corp
Overvalued
Healthcare Risk 49 · Elevated
Price$4.65
Model IV$3.84
P/IV1.21
Premium +21% Return to IV: -17.4%
Market implies +0.2%/yr vs model +50.0% · below model
DHR
DANAHER CORP /DE/
Deeply overvalued
Healthcare Risk 50 · Elevated
Price$202.63
Model IV$130.15
P/IV1.40
Premium +56% Return to IV: -35.8%
Market implies +9.1%/yr vs model +3.7% · above model
ELSE
ELECTRO SENSORS INC
Deeply overvalued
Healthcare Risk 55 · Elevated
Price$7.74
Model IV$3.91
P/IV1.97
Premium +98% Return to IV: -49.5%
Market implies +9.8%/yr vs model +5.9% · above model
FCUV
FOCUS UNIVERSAL INC.
Valuation N/A
Healthcare Risk 37 · Moderate
Price$5.62
Model IV—
P/IV—
Market implies +54.8%/yr vs model +2.0% · above model
FTV
Fortive Corp
Deeply overvalued
Healthcare Risk 61 · High
Price$61.71
Model IV$45.34
P/IV1.29
Premium +36% Return to IV: -26.5%
Market implies +6.9%/yr vs model +3.3% · above model
HURC
HURCO COMPANIES INC
Undervalued
Healthcare Risk 25 · Moderate
Price$22.52
Model IV$30.74
P/IV0.56
Discount 27% Return to IV: +36.5%
Market implies -4.2%/yr vs model +2.6% · below model
KEYS
Keysight Technologies, Inc.
Deeply overvalued
Healthcare Risk 57 · Elevated
Price$353.85
Model IV$84.02
P/IV4.03
Premium +321% Return to IV: -76.3%
Market implies +26.2%/yr vs model +6.4% · above model
MKSI
MKS INC
Deeply overvalued
Healthcare Risk 57 · Elevated
Price$306.29
Model IV$71.04
P/IV4.56
Premium +331% Return to IV: -76.8%
Market implies +29.1%/yr vs model +8.2% · above model
MLAB
MESA LABORATORIES INC /CO/
Fairly valued
Healthcare Risk 36 · Moderate
Price$106.04
Model IV$96.97
P/IV1.05
Premium +9% Return to IV: -8.6%
Market implies +11.8%/yr vs model +14.1% · in line
POAS
PHAOS TECHNOLOGY HOLDINGS (CAYMAN) Ltd
Valuation N/A
Healthcare Risk 27 · Moderate
Price$0.17
Model IV—
P/IV—
Market implies +17.2%/yr vs model +15.0% · in line
RAL
Ralliant Corp
Deeply overvalued
Healthcare Risk 58 · Elevated
Price$72.29
Model IV$28.44
P/IV2.18
Premium +154% Return to IV: -60.7%
Market implies +16.2%/yr vs model +3.0% · above model
ROP
ROPER TECHNOLOGIES INC
Deeply undervalued
Healthcare Risk 32 · Moderate
Price$397.50
Model IV$995.98
P/IV0.33
Discount 60% Return to IV: +150.6%
Market implies -1.0%/yr vs model +12.2% · below model
SENS
Senseonics Holdings, Inc.
Deeply overvalued
Healthcare Risk 66 · High
Price$7.81
Model IV$2.41
P/IV2.82
Premium +225% Return to IV: -69.2%
Market implies +20.8%/yr vs model +50.0% · below model
ST
Sensata Technologies Holding plc
Deeply overvalued
Healthcare Risk 56 · Elevated
Price$45.42
Model IV$26.07
P/IV1.96
Premium +74% Return to IV: -42.6%
Market implies +12.6%/yr vs model +5.0% · above model
SYPR
SYPRIS SOLUTIONS INC
Deeply undervalued
Healthcare Risk 28 · Moderate
Price$2.06
Model IV$6.71
P/IV0.49
Discount 69% Return to IV: +225.6%
Market implies -23.6%/yr vs model +5.3% · below model